Mirendil develops AI models to accelerate breakthroughs in biology and materials science. Its AI discovery engine simulates molecular interactions and explores chemical space to speed up drug and material discovery, potentially integrating with robotic wet labs. Distinguishing factors include its neo-lab model, focusing on niche, science-driven applications rather than general-purpose AI, and a team of researchers from Anthropic and other AI labs with experience in scientific reasoning. The company’s goal is to shorten the time and reduce the cost of research and development by acting as a scientific co-pilot that guides experiments and simulations toward promising discoveries.
Company Size
11-50
Company Stage
Series A
Total Funding
$1.2B
Headquarters
San Francisco, California
Founded
2026
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?